Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 20:19:23 UTC |
---|
Update Date | 2021-09-26 23:15:44 UTC |
---|
HMDB ID | HMDB0258655 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Syrosingopine |
---|
Description | Syrosingopine belongs to the class of organic compounds known as yohimbine alkaloids. These are alkaloids containing the pentacyclic yohimban skeleton. The Yohimbinoid alkaloids contain a carbocyclic ring E arising through C-17 to C-18 bond formation in a corynantheine precursor. Based on a literature review a significant number of articles have been published on Syrosingopine. This compound has been identified in human blood as reported by (PMID: 31557052 ). Syrosingopine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Syrosingopine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCOC(=O)OC1=C(OC)C=C(C=C1OC)C(=O)OC1CC2CN3CCC4=C(NC5=C4C=CC(OC)=C5)C3CC2C(C1OC)C(=O)OC InChI=1S/C35H42N2O11/c1-7-46-35(40)48-31-26(42-3)12-18(13-27(31)43-4)33(38)47-28-14-19-17-37-11-10-22-21-9-8-20(41-2)15-24(21)36-30(22)25(37)16-23(19)29(32(28)44-5)34(39)45-6/h8-9,12-13,15,19,23,25,28-29,32,36H,7,10-11,14,16-17H2,1-6H3 |
---|
Synonyms | Value | Source |
---|
Methyl 17-{4-[(ethoxycarbonyl)oxy]-3,5-dimethoxybenzoyloxy}-6,18-dimethoxy-3,13-diazapentacyclo[11.8.0.0,.0,.0,]henicosa-2(10),4(9),5,7-tetraene-19-carboxylic acid | HMDB |
|
---|
Chemical Formula | C35H42N2O11 |
---|
Average Molecular Weight | 666.724 |
---|
Monoisotopic Molecular Weight | 666.27886018 |
---|
IUPAC Name | methyl 17-{4-[(ethoxycarbonyl)oxy]-3,5-dimethoxybenzoyloxy}-6,18-dimethoxy-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4(9),5,7-tetraene-19-carboxylate |
---|
Traditional Name | methyl 17-{4-[(ethoxycarbonyl)oxy]-3,5-dimethoxybenzoyloxy}-6,18-dimethoxy-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4(9),5,7-tetraene-19-carboxylate |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCOC(=O)OC1=C(OC)C=C(C=C1OC)C(=O)OC1CC2CN3CCC4=C(NC5=C4C=CC(OC)=C5)C3CC2C(C1OC)C(=O)OC |
---|
InChI Identifier | InChI=1S/C35H42N2O11/c1-7-46-35(40)48-31-26(42-3)12-18(13-27(31)43-4)33(38)47-28-14-19-17-37-11-10-22-21-9-8-20(41-2)15-24(21)36-30(22)25(37)16-23(19)29(32(28)44-5)34(39)45-6/h8-9,12-13,15,19,23,25,28-29,32,36H,7,10-11,14,16-17H2,1-6H3 |
---|
InChI Key | ZCDNRPPFBQDQHR-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as yohimbine alkaloids. These are alkaloids containing the pentacyclic yohimban skeleton. The Yohimbinoid alkaloids contain a carbocyclic ring E arising through C-17 to C-18 bond formation in a corynantheine precursor. |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | Yohimbine alkaloids |
---|
Sub Class | Not Available |
---|
Direct Parent | Yohimbine alkaloids |
---|
Alternative Parents | |
---|
Substituents | - Yohimbine
- Corynanthean skeleton
- Yohimbine alkaloid
- Beta-carboline
- Pyridoindole
- Gallic acid or derivatives
- M-methoxybenzoic acid or derivatives
- Benzoate ester
- M-dimethoxybenzene
- Dimethoxybenzene
- 3-alkylindole
- Indole
- Indole or derivatives
- Benzoic acid or derivatives
- Phenoxy compound
- Anisole
- Phenol ether
- Methoxybenzene
- Benzoyl
- Alkyl aryl ether
- Aralkylamine
- Piperidine
- Carbonic acid diester
- Monocyclic benzene moiety
- Dicarboxylic acid or derivatives
- Benzenoid
- Pyrrole
- Heteroaromatic compound
- Methyl ester
- Tertiary amine
- Carboxylic acid ester
- Carbonic acid derivative
- Tertiary aliphatic amine
- Amino acid or derivatives
- Azacycle
- Organoheterocyclic compound
- Carboxylic acid derivative
- Ether
- Dialkyl ether
- Organooxygen compound
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organonitrogen compound
- Carbonyl group
- Organic oxygen compound
- Organopnictogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Syrosingopine,1TMS,isomer #1 | CCOC(=O)OC1=C(OC)C=C(C(=O)OC2CC3CN4CCC5=C(C4CC3C(C(=O)OC)C2OC)N([Si](C)(C)C)C2=CC(OC)=CC=C52)C=C1OC | 4956.9 | Semi standard non polar | 33892256 | Syrosingopine,1TMS,isomer #1 | CCOC(=O)OC1=C(OC)C=C(C(=O)OC2CC3CN4CCC5=C(C4CC3C(C(=O)OC)C2OC)N([Si](C)(C)C)C2=CC(OC)=CC=C52)C=C1OC | 4553.5 | Standard non polar | 33892256 | Syrosingopine,1TMS,isomer #1 | CCOC(=O)OC1=C(OC)C=C(C(=O)OC2CC3CN4CCC5=C(C4CC3C(C(=O)OC)C2OC)N([Si](C)(C)C)C2=CC(OC)=CC=C52)C=C1OC | 6781.9 | Standard polar | 33892256 | Syrosingopine,1TBDMS,isomer #1 | CCOC(=O)OC1=C(OC)C=C(C(=O)OC2CC3CN4CCC5=C(C4CC3C(C(=O)OC)C2OC)N([Si](C)(C)C(C)(C)C)C2=CC(OC)=CC=C52)C=C1OC | 5063.7 | Semi standard non polar | 33892256 | Syrosingopine,1TBDMS,isomer #1 | CCOC(=O)OC1=C(OC)C=C(C(=O)OC2CC3CN4CCC5=C(C4CC3C(C(=O)OC)C2OC)N([Si](C)(C)C(C)(C)C)C2=CC(OC)=CC=C52)C=C1OC | 4676.3 | Standard non polar | 33892256 | Syrosingopine,1TBDMS,isomer #1 | CCOC(=O)OC1=C(OC)C=C(C(=O)OC2CC3CN4CCC5=C(C4CC3C(C(=O)OC)C2OC)N([Si](C)(C)C(C)(C)C)C2=CC(OC)=CC=C52)C=C1OC | 6737.2 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Negative-QTOF | splash10-014i-0010019000-7fcde86a9944ec40fa60 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-014i-0000009000-94be94a76eac46eadbd6 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-004i-0891000000-bd01e1654c8d6b6c06f7 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-014i-0000009000-9cb2af563f1a3b63f2cc | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-00e9-0920000000-3e71f9d81714ecd653d5 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-014i-0000009000-ad63bcfc9f6a53d46deb | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-014i-0101009000-08a683d9f7694d308b87 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-014i-0010019000-96e4c968017538bfeeb1 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-014j-0428149000-043b11fe6e71f47b7e2f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-014i-0000009000-7b8fcc8bc8f0a15f651c | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-014l-0571097000-345a4298db27ac960814 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-014l-0561098000-22364e96cec7c2ca45df | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-014i-0000009000-a8575e8d3d75592e59e3 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-0fr6-0461096000-6fd2915804ae3ccd6d45 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-014i-0000009000-d47079b17a2086c867f5 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-014i-0000009000-c2b599badcc44eb57592 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-014j-0327149000-be073b2ea45030a3bbfe | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-014i-0101009000-d9d371e8401c3714e8e3 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-004i-0591000000-6bffe3f305092fe13905 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-014i-0100019000-8fdd61b01e56d31d9e57 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-00e9-0910000000-6d819b182ab053ff366a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-014j-0428149000-77afccdf556a6aee84c0 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Syrosingopine 6V, Positive-QTOF | splash10-004i-0691000000-2b9734bc04e33b22f0f5 | 2021-09-20 | HMDB team, MONA | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 5174 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Syrosingopine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 5367 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]
|
---|